Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Azenosertib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 393,691Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zentalis Pharma Reveals Four Azenosertib Posters Presentations
    Zentalis Pharma Reveals Four Azenosertib Posters Presentations

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165795/0/en/Zentalis-Pharmaceuticals-Announces-Four-Azenosertib-Posters-Presentations-at-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share
    Zentalis Pharmaceuticals Reports Q1 2025 Financial Results
    Zentalis Pharmaceuticals Reports Q1 2025 Financial Results

    14 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/14/3081574/0/en/Zentalis-Pharmaceuticals-Reports-First-Quarter-2025-Financial-Results-and-Operational-Progress.html

    GLOBENEWSWIRE
    14 May 2025
    Share Share
    Zentalis Doses First Patient in Azenosertib Trial (PROC)
    Zentalis Doses First Patient in Azenosertib Trial (PROC)

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069146/0/en/Zentalis-Pharmaceuticals-Announces-First-Patient-Dosed-in-DENALI-Part-2-Clinical-Trial-of-Azenosertib-in-Patients-with-Cyclin-E1-PROC.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Zentalis Pharmaceuticals Updates Clinical Data at SGO 2025 Meeting
    Zentalis Pharmaceuticals Updates Clinical Data at SGO 2025 Meeting

    15 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/15/3043285/0/en/Zentalis-Pharmaceuticals-Presents-Updated-Clinical-Data-at-the-Society-of-Gynecologic-Oncology-2025-Annual-Meeting-on-Women-s-Cancer.html

    GLOBENEWSWIRE
    15 Mar 2025
    Share Share
    Zentalis Reports Azenosertib Activity In Cyclin E1+ Ovarian Cancer
    Zentalis Reports Azenosertib Activity In Cyclin E1+ Ovarian Cancer

    29 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/29/3017038/0/en/Zentalis-Pharmaceuticals-Shares-Updated-Clinical-Data-Demonstrating-Meaningful-Azenosertib-Activity-in-Cyclin-E1-Platinum-Resistant-Ovarian-Cancer.html

    GLOBENEWSWIRE
    29 Jan 2025
    Share Share
    Zentalis Pharmaceuticals Restructures To Support Azenosertib
    Zentalis Pharmaceuticals Restructures To Support Azenosertib

    28 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/28/3016757/0/en/Zentalis-Pharmaceuticals-Announces-Strategic-Restructuring-to-Support-Late-Stage-Azenosertib-Development.html

    GLOBENEWSWIRE
    28 Jan 2025
    Share Share